Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1Î³.

Fiorentino, David F; Chung, Lorinda S; Christopher-Stine, Lisa; Zaba, Lisa; Li, Shufeng; Mammen, Andrew L; Rosen, Antony; Casciola-Rosen, Livia

Fiorentino, David F; Chung, Lorinda S; Christopher-Stine, Lisa; Zaba, Lisa; Li, Shufeng; Mammen, Andrew L; Rosen, Antony; Casciola-Rosen, Livia.

Affiliation

Fiorentino DF; Stanford University School of Medicine, Stanford, California.

Arthritis Rheum ; 65(11): 2954-62, 2013 Nov.

Article in En | MEDLINE | ID: mdl-24037894

Subject(s)

Adenosine Triphosphatases/immunology; Autoantibodies/blood; DNA-Binding Proteins/immunology; Dermatomyositis/epidemiology; Dermatomyositis/immunology; Neoplasms/epidemiology; Neoplasms/immunology; Pol1 Transcription Initiation Complex Proteins/immunology; Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies/analysis; Child; Child, Preschool; Female; Follow-Up Studies; HeLa Cells; Humans; Male; Middle Aged; Radioimmunoassay/methods; Risk Factors; Seroepidemiologic Studies; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Adenosine Triphosphatases / Pol1 Transcription Initiation Complex Proteins / Dermatomyositis / DNA-Binding Proteins / Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Arthritis Rheum Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google